Skip to main content

News

Establishment of the Ethics Advisory Board

Publiced on:

May 19, 2025

The Ethics Advisory Board members will advise us on ethical issues to ensure that our project complies with ethical standards and regulations.

Ethics Advisory Board members

Atia Cortés, Recognized researcher at the High Performance in AI group of the Barcelona Supercomputing Center (BSC-CNS). Atia specializes in the ethical, legal, socio-economic, and cultural aspects of AI, contributing to various EU-funded projects and initiatives.


Stefan Buijsman, Associate Professor Responsible AI at TU Delft, The Netherlands. Stefan’s research focuses on transparency and explainability of AI, and he leads the WHO Collaborating Centre on AI Governance and the TU Delft Digital Ethics Centre.


Ania Henley, is a Citizens and Patients Involvement Expert Advisor with over 25 years of experience in finance, clinical audits, and research data systems. She advises the NIHR Imperial Biomedical Research Centre for Multiple Long-Term Conditions at Imperial College London, supporting patient-derived quality of care initiatives. She has served as Deputy Chair of the EIT Health Board on Ethical, Legal, and Social Issues, contributing to the Data Saves Lives initiative and the European Patient Forum. At Imperial, she co-chaired the HEALTHYSTATS committee, helping develop a new way to communicate clinical trial results, published in BMJ Open Access, and supported the REACT COVID-19 studies.

More news

November 9, 2026

Save the Date: INDICATE Consortium Meeting 2027 in Barcelona

November 9, 2026

INDICATE Datathon 2027: Turning Research Ideas into Action

November 3, 2026

INDICATE and Flower Labs join forces to advance federated learning in intensive care research

October 20, 2026

INDICATE WP5 to Host Training & Education Session in Brussels on 1–2 December 2026

October 19, 2026

INDICATE visits Innocens to bridge the gap from clinical AI research to real-world impact

October 15, 2026

INDICATE presents pilot results on AI education and implementation readiness at ESCIM LIVES 2026 | Lisbon – Day III